A Phase I Dose Intensification Study Using Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Patients With Inoperable, Non-Small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 04 May 2016
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 27 Jan 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 05 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 17 Dec 2009 Planned end date changed from 11 Jun 2009 to 11 Jun 2010 as reported by ClinicalTrials.gov.